Dermata Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.About DRMA
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
CEOGerald T. Proehl
CEOGerald T. Proehl
Employees8
Employees8
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees8
Employees8
DRMA Key Statistics
Market cap4.12M
Market cap4.12M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume33.80K
Average volume33.80K
High today$6.67
High today$6.67
Low today$6.12
Low today$6.12
Open price$6.32
Open price$6.32
Volume8.12K
Volume8.12K
52 Week high$28.80
52 Week high$28.80
52 Week low$5.74
52 Week low$5.74
People also own
Based on the portfolios of people who own DRMA. This list is generated using Robinhood data, and it’s not a recommendation.